Navigation Links
Almac and the Royal Society of Chemistry Host a Workshop on the use of Analytical Techniques to Control and Monitor Solid Form
Date:11/19/2010

Almac and the Royal Society of Chemistry Host a Workshop on... -- CRAIGAVON, Northern Ireland, November 19, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Pharmaceuticals, Chemical, New Products & Services, Trade Show News Click to view news release full screen  

Almac and the Royal Society of Chemistry Host a Workshop on the use of Analytical Techniques to Control and Monitor Solid Form

 

CRAIGAVON, Northern Ireland, November 19, 2010 /PRNewswire/ -- Almac, in association with the Royal Society of Chemistry, hosted a scientific workshop focusing on advanced analytical techniques used to optimise, monitor and control solid state properties during the development of new medicines.

The milestone event, attended by representatives from industry and academia, included presentations and round table discussion regarding x-ray powder diffraction, hyper differential scanning calorimetry and Raman spectroscopy.

An important element of the workshop was the presentation of results from Almac's collaborative research with Queens University Belfast regarding Raman spectroscopy. 'The effect of crystal orientation on Raman Spectra' has been observed for the first time and these findings will have profound implications for the use of this technique in characterising physical forms.

Linda McCausland, Head of Physical Sciences, Almac, commented: "Almac has invested extensively in research and development in the field of solid state science and is currently involved in a number of academic collaborations. The research output of these studies will be available to clients to augment the development of their drugs. This workshop provided an opportunity for Almac to share its expertise with the pharmaceutical community and we are very proud to have worked with the Royal Society of Chemistry in staging such an exciting event."

She added: "The insight harnessed from the study's findings is testimony to Almac's status as a leader in the field of solid state science."

Prof Duncan Burns, Analytical Division, Royal Society of Chemistry, remarked: "The workshop was a truly memorable day of excellent and well presented analytical science."

Notes to Editors:

About Almac

The Almac Group offers a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors. The company employs almost 3,000 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Almac has officially gained full possession of its new $120m North American Headquarters which started in July 2008 and employees will relocate during the fall.

For more information on Almac, please visit http://www.almacgroup.com


'/>"/>
SOURCE Almac
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment
2. Almacs North American Headquarters Opens its Doors for Audits
3. Almacs Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection
4. Almac Launch Biomarkers for Biopharma
5. Royalty Pharma Announces that Alexander von Perfall Joins Management Team
6. Unilens Vision Reports Record First Quarter Earnings and Royalty Income
7. Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program
8. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
9. Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
10. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
11. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... celebrate the profession and recognize the positive impact veterinarians have on animal health ... and the World Organization for Animal Health (OIE) choose a theme each year ...
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Beginning in ... of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure ... changing the formula in the following ways:, , Removal of ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
Breaking Medicine News(10 mins):